{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/angio-oedema-anaphylaxis/diagnosis/diagnosis-of-anaphylaxis/","result":{"pageContext":{"chapter":{"id":"bf860a63-b9a4-5c14-bf1b-46423d3df7ad","slug":"diagnosis-of-anaphylaxis","fullItemName":"Diagnosis of anaphylaxis","depth":2,"htmlHeader":"<!-- begin field 80ccfc48-ed26-472d-b1bd-a77d00ffbc15 --><h2>How should I diagnose anaphylaxis?</h2><!-- end field 80ccfc48-ed26-472d-b1bd-a77d00ffbc15 -->","summary":"","htmlStringContent":"<!-- begin item 13654274-eea4-4815-81a0-a77d00ffba2a --><!-- begin field 6747fd94-c148-4a52-b71d-a77d00ffbc15 --><p><strong>The Working Group of the Resuscitation Council (UK) advises that the Airway, Breathing, Circulation, Disability, and Exposure (ABCDE) approach (summarized below) is used to recognize (and <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/management/anaphylaxis-with-or-without-angio-oedema/#management\">manage</a>) people with suspected anaphylaxis. For detailed information on this approach, see Appendix 1 of the <a href=\"https://www.resus.org.uk/anaphylaxis/emergency-treatment-of-anaphylactic-reactions/\" data-hyperlink-id=\"ad28c1fe-13cb-4788-a354-a991002b67e2\">Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers</a> available on the Resuscitation Council (UK) website (<a href=\"https://www.resus.org.uk/\" data-hyperlink-id=\"765588e3-b5c9-4ea7-a0b3-a991002b6866\">www.resus.org.uk</a>).</strong></p><ul><li><strong>Anaphylaxis is likely when all of the following 3 criteria are met:</strong><ul><li><strong>Sudden onset and rapid progression of symptoms.</strong><ul><li>The person will feel and look unwell.</li><li>Most reactions occur over several minutes. Rarely, reactions may be slower in onset.</li><li>The time of onset of an anaphylactic reaction will depend on the type of trigger. For example, an intravenous trigger will cause a more rapid onset of reaction than stings, which tend to cause a more rapid onset than orally ingested triggers.</li><li>The person will appear anxious and can experience a 'sense of impending doom'.</li></ul></li><li><strong>Life-threatening Airway and/or Breathing and/or Circulation problems.</strong><ul><li><strong>A</strong>irway problems include airway swelling (for example throat and tongue swelling [pharyngeal/laryngeal oedema]), difficulty in breathing and swallowing (and a feeling of the throat closing up), hoarse voice, and stridor (a high-pitched inspiratory noise caused by upper airway obstruction).</li><li><strong>B</strong>reathing problems include shortness of breath (increased respiratory rate), wheeze, tiredness, confusion (caused by hypoxia), cyanosis (the person appears blue; this is usually a late sign), peripheral capillary oxygen saturation (SpO<sub>2</sub>) less than 92%, and respiratory arrest.</li><li><strong>C</strong>irculatory problems include signs of shock (pale, clammy), increased pulse rate (tachycardia), low blood pressure (feeling faint, dizziness, collapse), decreased level (or loss) of consciousness, and cardiac arrest. Anaphylaxis can also cause myocardial ischaemia and electrocardiograph (ECG) changes even in people with normal coronary arteries.</li><li>These <strong>A</strong>irway, <strong>B</strong>reathing, and <strong>C</strong>irculation problems can alter the person’s neurological status (<strong>D</strong>isability problems) because of decreased brain perfusion, and there may be confusion and agitation.</li></ul></li><li><strong>Skin and/or mucosal changes.</strong><ul><li>These should be assessed as part of the <strong>E</strong>xposure when using the ABCDE approach.</li><li>They are often the first features, present in over 80% of anaphylactic reactions, and can be subtle or dramatic.</li><li>There may be erythema (a patchy or generalized red rash), urticaria, or angio-oedema.</li></ul></li></ul></li><li><strong>The diagnosis of anaphylaxis is supported by</strong> the person's exposure to a known <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/background-information/causes-trigger-factors/\">allergen</a>.</li><li><strong>Be aware that:</strong><ul><li>Skin changes without life-threatening airway, breathing, or circulation problems do not signify an anaphylactic reaction. Most people who have allergic skin changes do not go on to develop an anaphylactic reaction.</li><li>Skin and mucosal changes can be subtle or absent in up to 20% of reactions. Some people may present with only a decrease in blood pressure (a circulation problem).</li><li>There may also be gastrointestinal symptoms (such as vomiting, abdominal pain, and incontinence).</li><li>Occasionally a biphasic anaphylactic reaction may occur.<ul><li>This is a potentially life-threatening recurrence of symptoms after the initial presentation, without re-exposure to the trigger. The infrequent nature of these reactions makes them difficult to predict.</li><li>Biphasic reactions are less likely among people with food-induced anaphylaxis, but people who present with hypotension or have idiopathic anaphylaxis may be at increased risk. </li></ul></li></ul></li></ul><!-- end field 6747fd94-c148-4a52-b71d-a77d00ffbc15 --><!-- end item 13654274-eea4-4815-81a0-a77d00ffba2a -->","topic":{"id":"4e83ca20-0eac-5432-adf1-cb9a0716c558","topicId":"41b219ac-b62a-42d3-9d76-7b3897b21bdd","topicName":"Angio-oedema and anaphylaxis","slug":"angio-oedema-anaphylaxis","lastRevised":"Last revised in November 2018","chapters":[{"id":"f7de7576-f193-57e1-8566-52f77c198d07","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"137d41e2-195c-5b6c-a42b-a2e7774ab4c5","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2d19b26a-ca5e-5feb-8be8-12f596f24eed","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"76defb8d-d620-56bc-bf42-cc72dd02704f","slug":"changes","fullItemName":"Changes"},{"id":"0124664c-1848-504a-b629-b001f3d627e7","slug":"update","fullItemName":"Update"}]},{"id":"fd3fe5d3-198d-5e2e-afaa-1de509ee14b0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8c36d3c5-8fc2-58ba-91d9-2d00dbb17605","slug":"goals","fullItemName":"Goals"},{"id":"dbfbfeb0-8ad4-5a3d-8458-06af672eab12","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bbc732dc-6fbc-5902-a5bf-890776f1df44","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"49ccfcd1-6054-5eac-b6a2-c85eb605ecfd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4c97855a-e489-54e6-8f4b-28dbc050951e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"71eafab9-7c66-5e57-aa08-197ad09eb9e7","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2c158e9f-bfe1-56ea-a1fe-97e4da83b82d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ed1b7bb1-0232-5ceb-991c-c936ac2a3086","slug":"definition","fullItemName":"Definition"},{"id":"ac67665b-2b88-5df8-9a70-cc35f96825ae","slug":"causes-trigger-factors","fullItemName":"Causes/trigger factors"},{"id":"a4358430-db1f-55c2-9d68-6ce8076813ba","slug":"prevalence","fullItemName":"Prevalence"},{"id":"7ebee135-258e-58ce-a91e-947b8a2f9563","slug":"complications","fullItemName":"Complications"},{"id":"7c2a6ca1-0f6a-5a40-bc06-dbbbf95c57c1","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4b20303c-5905-594a-a8c6-4f85e46cf3f9","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"005b06b8-18c4-569f-b1b3-3c6d1218ddf7","slug":"diagnosis-of-angio-oedema","fullItemName":"Diagnosis of angio-oedema"},{"id":"682e56cf-4c4d-5736-8db7-4cd4bfcab6e2","slug":"assessing-the-cause-of-angio-oedema","fullItemName":"Assessing the cause of angio-oedema"},{"id":"bf860a63-b9a4-5c14-bf1b-46423d3df7ad","slug":"diagnosis-of-anaphylaxis","fullItemName":"Diagnosis of anaphylaxis"},{"id":"fab5c932-e15e-5303-99e9-48f7d2e415b4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1c5f38ef-17d4-569d-ad54-b819fd953d6c","fullItemName":"Management","slug":"management","subChapters":[{"id":"654a5e70-49b7-58b4-b976-7e94c44b3074","slug":"angio-oedema-without-anaphylaxis","fullItemName":"Scenario: Angio-oedema without anaphylaxis"},{"id":"5759117d-4bde-53b6-b78d-7885ccbf431e","slug":"anaphylaxis-with-or-without-angio-oedema","fullItemName":"Scenario: Anaphylaxis with or without angio-oedema"}]},{"id":"6f94e28f-193d-587a-a11a-0a05a1be037f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b59ab8fd-de1f-555e-946a-c3a53b918da4","slug":"emergency-drug-doses","fullItemName":"Emergency drug doses"},{"id":"69e007b8-2046-5946-a7b5-de8f1bb9de9f","slug":"non-sedating-antihistamines-no-airway-involvement","fullItemName":"Non-sedating antihistamines (no airway involvement)"},{"id":"dac089ca-3b63-536d-9737-82806f78b88e","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"}]},{"id":"7ead2f48-36a4-5547-8570-4d4ab5898a73","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a7653e34-460d-5737-b0c3-264ecc26dc68","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a713ee82-3188-50ea-a2bc-a562abd97621","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7421fd02-2e34-5526-bd39-905aa772f800","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d24df800-eddc-5bf3-bea0-d556b5e01aed","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"af27ed5c-0853-5d16-91a4-5e5878ee9209","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f7640a76-8bc4-569e-8b82-717e6bd5f041","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b4778aa1-f37d-574f-8514-47ac86bf2c2e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4b20303c-5905-594a-a8c6-4f85e46cf3f9","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"1baca1aa-3a9c-51b4-80a8-8682c90f0bac","slug":"basis-for-recommendation-ba3","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 95dba4db-5fdf-485a-9612-a782013a68ac --><h3>Basis for recommendation</h3><!-- end field 95dba4db-5fdf-485a-9612-a782013a68ac -->","summary":null,"htmlStringContent":"<!-- begin item ba36ee79-45e4-44cd-8c64-a782013a683f --><!-- begin field 4da37bef-ef2e-40b2-9669-a782013a68ac --><p>These recommendations are largely based on the <em>Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers </em>published by the Working Group of the Resuscitation Council (UK) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Resuscitation Council (UK), 2012</a>].</p><ul><li>Resuscitation Council (UK) advises that there is no single set of criteria that will identify all anaphylactic reactions, but the listed combinations of signs make the diagnosis of an anaphylactic reaction more likely.</li><li>The information on biphasic anaphylactic reactions is also taken from a systematic review and meta-analysis on the time of onset and predictors of biphasic anaphylactic reactions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Lee, 2015</a>].</li></ul><!-- end field 4da37bef-ef2e-40b2-9669-a782013a68ac --><!-- end item ba36ee79-45e4-44cd-8c64-a782013a683f -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}